The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Amedisys
AMED
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$97.56
0.09
0.09%
At Close: -
$97.56
0
0.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Amedisys (AMED) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Amedisys (NASDAQ:AMED) Stock
Amedisys Stock (NASDAQ: AMED)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, August 21, 2024
Contessa Health, A Subsidiary Of Amedisys Ann...
Benzinga Newsdesk
Wednesday, July 31, 2024
Deutsche Bank Downgrades Amedisys to Hold, Ma...
Benzinga Newsdesk
Friday, July 26, 2024
AMED vs. USPH: Which Stock Is the Better Value Option?
Zacks
Thursday, July 25, 2024
Cantor Fitzgerald Reiterates Neutral on Amedi...
Benzinga Newsdesk
Wednesday, July 24, 2024
Amedisys Q2 EPS $1.32 Beats $1.18 Estimate, S...
Benzinga Newsdesk
Monday, July 01, 2024
William Blair Downgrades Amedisys to Market P...
Benzinga Newsdesk
Thursday, April 25, 2024
Cantor Fitzgerald Reiterates Neutral on Amedi...
Benzinga Newsdesk
Wednesday, April 24, 2024
Amedisys Q1 2024 Adj EPS $1.03 Beats $1.02 Es...
Benzinga Newsdesk
Tuesday, March 26, 2024
Raymond James Maintains Market Perform on Ame...
Benzinga Newsdesk
Monday, March 25, 2024
RBC Capital Maintains Outperform on Amedisys,...
Benzinga Newsdesk
Tuesday, March 05, 2024
Amedisys Q4 2023 Adj EPS $0.940 Misses $1.030...
Benzinga Newsdesk
Wednesday, February 21, 2024
Amedisys Q4 2023 Adj EPS $0.94 Misses $1.03 E...
Benzinga Newsdesk
Thursday, February 08, 2024
Amedisys Offers Molecular Testing For Rapid A...
Benzinga Newsdesk
Friday, December 29, 2023
Richard Ashworth Exercises Options, Realizes $171K
Benzinga Insights
Tuesday, October 24, 2023
Amedisys Q3 Adj. EPS $0.98 Misses $1.08 Estim...
Benzinga Newsdesk
Thursday, September 14, 2023
Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know
Benzinga Insights
Cantor Fitzgerald Maintains Neutral on Amedis...
Benzinga Newsdesk
Monday, July 31, 2023
TD Cowen Maintains Market Perform on Amedisys...
Benzinga Newsdesk
Thursday, July 27, 2023
What 11 Analyst Ratings Have To Say About Amedisys
Benzinga Insights
Credit Suisse Reiterates Neutral on Amedisys,...
Benzinga Newsdesk
Wednesday, July 26, 2023
Amedisys Q2 Adj EPS $1.37 Beats $1.09 Estimat...
Benzinga Newsdesk
Thursday, July 06, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
Benzinga Insights
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Lisa Levin
Jefferies Downgrades Amedisys to Hold, Raises...
Benzinga Newsdesk
Wednesday, June 28, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
Benzinga Insights
Tuesday, June 27, 2023
Analyst Ratings for Amedisys
Benzinga Insights
Benchmark Downgrades Amedisys to Hold
Benzinga Newsdesk
Truist Securities Maintains Hold on Amedisys,...
Benzinga Newsdesk
Monday, June 26, 2023
Option Care Health Confirms Termination Of Merger Agreement With Amedisys; As Part Of The Mutual Termination Agreement, Option Care Health Will Receive A $106M Termination Fee
Happy Mohamed
Amedisys, Inc And Aurora Holdings Merger Sub Inc., A Wholly-Owned Subsidiary Of UnitedHealth Group Entered Into An Agreement And Plan Of Merger Agreement For The Acquisition Of Amedisys's Outstanding Stock In An All-Cash Transaction For $101/Share
Happy Mohamed
Wednesday, June 07, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Benzinga Insights
Truist Securities Downgrades Amedisys to Hold...
Benzinga Newsdesk
Tuesday, June 06, 2023
Expert Ratings for Amedisys
Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
Benzinga Insights
Cantor Fitzgerald Maintains Neutral on Amedis...
Benzinga Newsdesk
Benchmark Reiterates Buy on Amedisys, Maintai...
Benzinga Newsdesk
Credit Suisse Downgrades Amedisys to Neutral,...
Benzinga Newsdesk
Monday, June 05, 2023
Optum's Decision To Target Amedisys Is Intriguing, Says Analyst
Vandana Singh
Why Shares Of Amedisys Inc Are Rising
Ryan Gustafson
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Amedysis shares are trading higher after the ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Amedisys Shares Resume Trading, Spike Higher
Benzinga Newsdesk
Amedisys Announces Receipt of Unsolicited Pro...
Benzinga Newsdesk
Wednesday, May 10, 2023
Amedisys's Return On Capital Employed Overview
Benzinga Insights
Monday, May 08, 2023
TD Cowen Maintains Market Perform on Amedisys...
Benzinga Newsdesk
Friday, May 05, 2023
Barclays Maintains Equal-Weight on Amedisys, ...
Benzinga Newsdesk
Thursday, May 04, 2023
Analyst Expectations for Amedisys's Future
Benzinga Insights
Truist Securities Maintains Buy on Amedisys, ...
Benzinga Newsdesk
Healthcare Giants Join Hands: Option Care Health Acquires Amedisys in a $3.6 Billion Stock Swap
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch